Boswellia serrata extract

DRUG3 trials

Sponsors

Ali Altunkaya, Medical University of Graz, Brigham and Women's Hospital

Conditions

Brain and Central Nervous System TumorsCentral SensitisationCerebral EdemaChronic PainNeuroinflammatory ResponsePeripheral SensitizationProstate Cancer

Phase 2

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

TerminatedNCT00243022

Ali AltunkayaBrain and Central Nervous System Tumors, Cerebral Edema

Start: 2004-09-30End: 2011-03-31Updated: 2019-04-30

Study of Boswellia for Urinary Toxicity in Prostate Cancer Radiotherapy

Not yet recruitingNCT07867158

Brigham and Women's HospitalProstate Cancer

Start: 2026-10-01End: 2027-06-01Target: 20Updated: 2026-10-09

Unknown Phase

Effect of Boswellia Serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers

RecruitingNCT07109843

Medical University of GrazCentral Sensitisation, Chronic Pain, Neuroinflammatory Response +1

Start: 2025-09-01End: 2025-12-31Target: 12Updated: 2025-09-24

Related Papers

Synergistic combination of PMBA and 5-fluorouracil (5-FU) in targeting mutant KRAS in 2D and 3D colorectal cancer cells.

2022-03-165 citations